title: Absolute benefits of aromatase inhibitors in adjuvant treatment of breast cancer: should we know more?
authors.forename: Bostjan
authors.initials: B
authors.lastname: Seruga
authors.forename: Alberto
authors.initials: A
authors.lastname: Ocana
authors.forename: Saroj
authors.initials: S
authors.lastname: Niraula
authors.forename: Eitan
authors.initials: E
authors.lastname: Amir
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D015201:Meta-Analysis as Topic; D012107:Research Design
chemical_list: D000970:Antineoplastic Agents; D047072:Aromatase Inhibitors